Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVB
#3994
Nuvation Bio Inc.
5.9
2
+5.71%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+5.71%
Monthly Change
+5.53%
6 month change
+98.66%
Year Change
+203.59%
Previous Close
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
Volume
1 640
Markets
US Stock Market
Healthcare
NUVB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
216.65 M
218.06 M
217.8 M
218.05 M
337.68 M
—
Valuation ratios
Enterprise value
—
18.62 T
4.44 T
645.16 M
1.77 B
4.12 B
Price to earnings ratio
—
—
-4.21
-4.49
-1.26
-13.64
Price to sales ratio
—
—
-0.37
-2.66
0.09
0.22
Price to cash flow ratio
—
—
0
0.01
0.01
0.02
Price to book ratio
—
—
0
0
0
0
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
—
-0.11
-0.16
-0.12
-1.05
-0.38
Return on equity %
—
-0.12
-0.16
-0.13
-1.22
-0.56
Return on invested capital %
—
-502.05
-8 731.74
-6 118.89
-11.72 K
-2 524.3
Gross margin %
—
100
100
100
10.1
179.45
Operating margin %
—
-54.25 K
10.16 K
77.38 K
-7 527.33
-4 603.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
-50.49 K
8 845.42
58.76 K
-7 213.76
-4 238.15
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
0.46
45.62
50.7
44.11
9.04
35.92
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
-0
-0
0.01
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-443.46
-310.67
-485.22
-595.27
EBIT per share
—
—
—
—
-2 204.94
-727.84
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3 050.07
2 792.46
1 870.33
6 634.85
Net current asset value per share
—
—
3 079.16
2 816.31
1 958
6 892.76
Tangible book value per share
—
—
3 022.67
2 764.63
1 708.38
4 918.68
Working capital per share
—
—
3 018.43
2 752.47
1 741.29
6 124.83
Book value per share
—
—
3 022.67
2 764.63
1 725.58
5 018.94
News
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright
Nuvation Bio stock rating reiterated at Market Outperform by Citizens
Alibaba, American Express among market cap stock movers on Monday
Eisai to license taletrectinib for ROS1+ lung cancer across Europe, Asia